MAPT and Alzheimer disease: Mastrangelo and Bowers confirmed the predominant restriction of Aβ plaques and hyperphosphorylated tau to the hippocampus, amygdala, and cerebral cortex—the main foci of AD neuropathology in humans—in a comprehensive study [46].